Exodus Point Capital Management, LP Eye Point Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$8.67 - $14.11 $94,780 - $154,250	-10,932 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$10.18 - $18.4 $111,287 - $201,148	10,932 New	10,932 $134,000
Q3 2021 Nov 15, 2021	SELL	$7.51 - $11.72 $100,634 - $157,048	-13,400 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.69 - $11.08 $340,265 - $433,848	-39,156 Reduced 74.5%	13,400 $120,000
Q1 2021 May 17, 2021	BUY	$8.89 - $14.92 $467,222 - $784,135	52,556 New	52,556 $534,000

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.